CU6 clarity pharmaceuticals ltd

Ann: Last patient assessment completed for SARTATE trial, page-32

  1. 2,318 Posts.
    lightbulb Created with Sketch. 428
    From the journal article, we don't know if they're picking ALL lesions that are 2mm. You're extrapolating your assumptions, where the research has not indicated this at all. There is a long way to go to determine a level playing field yet flotsam.

    i agree there are plenty of cheerleaders for cu6, but I think you're pushing the whole new pet ct leveling the whole playing field a bit too much. Once there is more data regarding these new ct scanners, and it shows this unequivocally to be the case, I'll agree with you.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$4.38
Change
-0.280(6.01%)
Mkt cap ! $1.628B
Open High Low Value Volume
$4.62 $4.65 $4.30 $18.54M 4.185M

Buyers (Bids)

No. Vol. Price($)
5 14980 $4.35
 

Sellers (Offers)

Price($) Vol. No.
$4.39 2500 1
View Market Depth
Last trade - 16.10pm 07/08/2025 (20 minute delay) ?
CU6 (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.